Why Not Mandatory GLP-1s In Medicare For Obesity?
A Health Affairs Forefront Blog argues that GLP-1 coverage for obesity should be made mandatory. I have given great credit to the Trump administration for reducing drug prices, including with GLP-1s. But the proposed BALANCE reform model failed to attract enough health plans in the voluntary program. The government funding and risk mitigation just did not solve the fundamental risk problem, especially for standalone Part D (PDP) plans. Instead, Trump healthcare officials are proposing the BRIDGE program through 12/31/2027 to have the government cover the cost of such drugs for obesity.
The authors argue that voluntary BALANCE failed to attract plans so other options exist:
- Stripping intellectual property rights from drug makers, which obviously would be challenged.
- Making coverage of GLP-1s for obesity available in Medicare.
- Make the BALANCE program mandatory.
(Article may require a subscription.)
#glp1s #weightlossdrugs #drugpricing #medicare #medicareadvantage #partd #pdp
